Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents (Q34177765)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents
scientific article

    Statements

    Introduction: utilization of surrogate markers of atherosclerosis for the clinical development of pharmaceutical agents (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit